Literature DB >> 18839381

Local application of zoledronic acid incorporated in a poly(D,L-lactide)-coated implant accelerates fracture healing in rats.

Stefan H Greiner1, Britt Wildemann, David A Back, Mahtala Alidoust, Philipp Schwabe, Norbert P Haas, Gerhard Schmidmaier.   

Abstract

BACKGROUND AND
PURPOSE: Zoledronic acid (ZOL) has been shown in vitro and in vivo to inhibit osteoclastic activity and to regulate osteoblasts. Its antiresorptive effect is used clinically in the treatment of bone-consuming pathologies to prevent skeletal complications. Because of its effect on bone cells, there might be a possible benefit in treatment of fractures by local application from a biodegradable poly(D,L-lactide) (PDLLA) coating of osteosynthetic implants. We analyzed the effect of locally applied ZOL from a PDLLA coating of intramedullary implants on fracture healing.
MATERIAL AND METHODS: Standardized midshaft fractures of the right tibia of 5-month-old rats were stabilized either with uncoated, PDLLA-coated, or ZOL-coated implants. Animals were killed 42 or 84 days after fracture. Tibiae were dissected and mechanically tested. Results Radiographs taken 42 days after fracture showed at least unilateral bridging in all groups. Maximum load and torsional stiffness were highest in the group treated with ZOL. 84 days after fracture, the torsional stiffness of the ZOL-treated group remained higher than that of the uncoated group whereas the maximum load for the control groups reached the results for the ZOL-coated group.
INTERPRETATION: Local application of ZOL from PDLLA coating appears to accelerate the achievement of mechanical stability in fractures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18839381     DOI: 10.1080/17453670810016768

Source DB:  PubMed          Journal:  Acta Orthop        ISSN: 1745-3674            Impact factor:   3.717


  21 in total

Review 1.  Timing of the initiation of bisphosphonates after surgery for fracture healing: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Y-T Li; H-F Cai; Z-L Zhang
Journal:  Osteoporos Int       Date:  2014-09-30       Impact factor: 4.507

2.  Local delivery of zoledronate from a poly (D,L-lactide)-Coating increases fixation of press-fit implants.

Authors:  Thomas Jakobsen; Joan E Bechtold; Kjeld Søballe; Thomas Jensen; Stefan Greiner; Marianne T Vestermark; Jørgen Baas
Journal:  J Orthop Res       Date:  2015-07-31       Impact factor: 3.494

3.  Local delivery of zoledronate from a poly (d,l-lactide)-coating increases fixation of hydroxy-coated implants.

Authors:  Thomas Jakobsen; Joan E Bechtold; Kjeld Søballe; Thomas Jensen; Marianne T Vestermark; Jørgen Baas
Journal:  J Orthop Res       Date:  2017-04-11       Impact factor: 3.494

4.  Local bisphosphonate release versus hydroxyapatite coating for stainless steel screw fixation in rat tibiae.

Authors:  F Agholme; T Andersson; P Tengvall; P Aspenberg
Journal:  J Mater Sci Mater Med       Date:  2011-12-28       Impact factor: 3.896

5.  A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration.

Authors:  J S B Carvas; R M R Pereira; V F Caparbo; P Fuller; C A Silveira; L A P Lima; E Bonfa; S B V Mello
Journal:  Osteoporos Int       Date:  2009-12-09       Impact factor: 4.507

6.  Pharmacological agents and bone healing.

Authors:  Umberto Tarantino; Irene Cerocchi; Monica Celi; Alessandro Scialdoni; Luca Saturnino; Elena Gasbarra
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

7.  Surface immobilized zoledronate improves screw fixation in rat bone: a new method for the coating of metal implants.

Authors:  Therese Andersson; Fredrik Agholme; Per Aspenberg; Pentti Tengvall
Journal:  J Mater Sci Mater Med       Date:  2010-09-21       Impact factor: 3.896

Review 8.  Effects of anti-osteoporosis medications on fracture healing.

Authors:  Niklas R Jørgensen; Peter Schwarz
Journal:  Curr Osteoporos Rep       Date:  2011-09       Impact factor: 5.096

9.  Fracture healing with alendronate treatment in the Brtl/+ mouse model of osteogenesis imperfecta.

Authors:  J A Meganck; D L Begun; J D McElderry; A Swick; K M Kozloff; S A Goldstein; M D Morris; J C Marini; M S Caird
Journal:  Bone       Date:  2013-06-14       Impact factor: 4.398

10.  Effect of Age and Sodium Alendronate on Femoral Fracture Repair: Biochemical and Biomechanical Study in Rats.

Authors:  Luana Mordask Bonetto; Paola Fernanda Cotait de Lucas Corso; Gabrielle Grosko Kuchar; Jennifer Tsi Gerber; Leonardo Fernandes Cunha; Mohammed Elsalanty; João Cesar Zielak; Carla Castiglia Gonzaga; Rafaela Scariot
Journal:  Front Cell Dev Biol       Date:  2021-05-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.